Profil

Conteduca Giuseppina

See author's contact details
Main Referenced Co-authors
Baron, Frédéric  (3)
Beguin, Yves  (3)
Caers, Jo  (3)
Delvenne, Philippe  (3)
Drion, Pierre  (3)
Main Referenced Keywords
Treg (11); AIRE (8); CD8+ (4); Alopecia Areata (2); Azacytidine (2);
Main Referenced Unit & Research Centers
Centre of Excellence for Biomedical Research (6)
Centre of Excelence for Biomedical Research (3)
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (2)
CEBR, Centre of Excellence for Biomedical Research (1)
CEBR-Centre of Excelence for biomedical research (1)
Main Referenced Disciplines
Hematology (15)
Genetics & genetic processes (7)
Oncology (2)
Immunology & infectious disease (1)

Publications (total 25)

The most downloaded
800 downloads
Conteduca, G. (March 2012). Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells. Human Immunology, 73 (3), 207-13. doi:10.1016/j.humimm.2011.12.020 https://hdl.handle.net/2268/179694

The most cited

103 citations (Scopus®)

Conteduca, G. (June 2011). Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clinical Immunology, 139 (3), 249-57. doi:10.1016/j.clim.2011.01.013 https://hdl.handle.net/2268/179679

Conteduca, G., Indiveri, F., Filaci, G., & Negrini, S. (2018). Beyond APECED: An update on the role of the autoimmune regulator gene (AIRE) in physiology and disease. Autoimmunity Reviews, 17 (4), 325-330. doi:10.1016/j.autrev.2017.10.017
Peer Reviewed verified by ORBi

Conteduca, G. (16 November 2016). Different and synergistic effect of 5-Azacytidine and Rapamycin on ex vivo expansion of natural human T Regulatory cells [Poster presentation]. SFGM TC Congress 2016, Liège, Belgium.

Conteduca, G. (14 October 2016). Different and synergistic effect of 5-Azacytidine and Rapamycin on ex vivo expansion of natural human T Regulatory cells [Poster presentation]. Treg Symposium, Leuven, Belgium.

Conteduca, G. (2016). AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma. Oncotarget. doi:10.18632/oncotarget.11506
Peer Reviewed verified by ORBi

Fransolet, G.* , Ehx, G.* , SOMJA, J., Delens, L., Hannon, M., Muller, J., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., DELVENNE, P., BEGUIN, Y., Conteduca, G.* , & BARON, F.*. (04 July 2016). Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. Journal of Hematology and Oncology, 9, 53. doi:10.1186/s13045-016-0281-2
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Conteduca, G. (27 May 2016). 5-Azacytidine and Rapamycin: different and synergistic effect on ex vivo expansion of natural human T Regulatory cells [Paper presentation]. SIICA Congress 2016, Abano Terme, Italy.

Parodi, A., Traverso, P., Kalli, F., & Conteduca, G. (February 2016). Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence. Oncotarget, 7 (6), 6424-6435. doi:10.18632/oncotarget.7024

Fransolet, G., Ehx, G., SOMJA, J., Delens, L., Hannon, M., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., Belle, L., DELVENNE, P., BEGUIN, Y., Conteduca, G., & Baron, F. (29 January 2016). Azacytidine and Decitabine prevent experimental sclerodermic chronic graft-versus-host disease [Poster presentation]. 31st general annual meeting of the Belgian Hematological Society, La Hulpe, Belgium.

Fransolet, G., Ehx, G., SOMJA, J., Hannon, M., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., Belle, L., Delvenne, P., BEGUIN, Y., Conteduca, G., & Baron, F. (19 November 2015). L'Azacytidine comme traitement de la maladie du greffon contre l'hôte de type chronique sclérodermique expérimentale [Paper presentation]. 15ème congrès de la Société Française de Greffe de Moelle et de Thérapie Cellulaire, Clermont-Ferrand, France.

Conteduca, G. (19 November 2015). 5-Azacytidine and Rapamycin: different and synergistic effect on ex vivo expansion of natural human T Regulatory cells [Paper presentation]. 20th annual meeting: Advances in Immunomonitoring by Flow Cytometry, Anvers, Belgium.

Conteduca, G. (February 2014). Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata. Clinical and Experimental Medicine, 14 (1), 91-7. doi:10.1007/s10238-012-0224-3
Peer Reviewed verified by ORBi

Conteduca, G. (November 2013). AIRE polymorphisms induce variable extent of apoptosis on melanoma-specific CD8+ T lymphocytes [Poster presentation]. SITC 2013 Annual Meeting, National Harborn,MD, United States.

Conteduca, G. (October 2013). AIRE polymorphism, melanoma-antigen-specific T cell immunity, and susceptibility to melanoma [Poster presentation]. NIBIT meeting 2013, Siena, Italy.

Conteduca, G. (May 2013). Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice. Journal of Translational Medicine, 12 (11). doi:10.1186/1479-5876-11-120
Peer Reviewed verified by ORBi

Conteduca, G. (February 2013). Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. Human Immunology, 74 (2), 166-9. doi:10.1016/j.humimm.2012.11.008
Peer Reviewed verified by ORBi

Conteduca, G. (2013). CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes. Cancer Immunology, Immunotherapy, 62 (5), 851-62. doi:10.1007/s00262-013-1392-z
Peer Reviewed verified by ORBi

Conteduca, G. (November 2012). Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata. Clinical and Experimental Medicine, 14 (1), 91-7.
Peer Reviewed verified by ORBi

Conteduca, G. (March 2012). Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells. Human Immunology, 73 (3), 207-13. doi:10.1016/j.humimm.2011.12.020
Peer Reviewed verified by ORBi

Conteduca, G. (October 2011). AIRE polymorphisms induce variable extent of apoptosis on melanoma-specific CD8+ T lymphocytes [Poster presentation]. ESCII/NIBIT Meeting 2011, Siena, Italy.

Conteduca, G. (June 2011). Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clinical Immunology, 139 (3), 249-57. doi:10.1016/j.clim.2011.01.013
Peer Reviewed verified by ORBi

Conteduca, G. (July 2010). The role of AIRE polymorphisms in melanoma. Clinical Immunology, 136 (1), 96-104. doi:10.1016/j.clim.2010.03.002
Peer Reviewed verified by ORBi

Conteduca, G. (2010). Ruolo del gene AIRE nel melanoma [Doctoral thesis, Università degli studi di Genova]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/179686

Conteduca, G. (Other coll.). (2009). Aire controls the differentiation program of thymic epithelial cells in the medulla for the establishment of self-tolerance [Paper presentation]. Journal club, Genova, Italy.

Conteduca, G., Trombetta, D., Storlazzi, T. C., & Surace, C. (2008). Molecular characterization of double minutes/homogeneously staining regions in selected tumor cell lines. In D. Trombetta, A. Lonoce, M. C. Guastadisegni, C. Surace, G. Conteduca, G. Daniele, K. Kok, R. Ullmann, P. Vlies Van der, C. Buys, M. Rocchi, ... T. C. Storlazzi, the official journal of the International Society for Cellular Oncology.

Conteduca, G. (2008). AIRE role in melanoma [Poster presentation]. Italian Genetic association Congress, Genova, Italy.

Contact ORBi